269 Mill Road
5 articles with Asahi Kasei
Asahi Kasei has established industrial manufacturing technology for hyaluronic acid nanogel* as a new pharmaceutical excipient, and is providing samples to prospective customers in order to commercialize the product.
- Up to 250k USD investment per company to facilitate the development of products that utilize UVC LEDs for surface or air disinfection targeted towards viral or bacterial infections including COVID-19 - Currently accepting applications for funding at www.uvaccelerator.com [23-June-2020] GREEN ISLAND, N.Y. , June 23, 2020 /PRNewswire/ -- Asahi Kasei and Crys
Offers New Therapy for Treating Heart Patients in the Cath Lab
Aurora Resurgence, announced that its affiliate has entered into a definitive agreement to sell Cardiac Science Corporation, a leading provider of automated external defibrillators, related services and accessories, to ZOLL® Medical Corporation, an Asahi Kasei Group Company that manufactures medical devices and related software solutions.
First Commercial Patient Prescribed with the ZOLL µCor Heart Failure and Arrhythmia Management System